Transamerica Financial Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-3
Closed -$1K – 650
2023
Q4
$1K Hold
3
– – ﹤0.01% 491
2023
Q3
$1K Hold
3
– – ﹤0.01% 514
2023
Q2
$1K Buy
+3
New +$178 ﹤0.01% 485
2023
Q1
– Sell
-3
Closed -$1K – 658
2022
Q4
$1K Hold
3
– – ﹤0.01% 532
2022
Q3
$1K Hold
3
– – ﹤0.01% 500
2022
Q2
$1K Buy
+3
New +$190 ﹤0.01% 515
2020
Q3
– Sell
-3
Closed -$1K – 328
2020
Q2
$1K Buy
+3
New +$151 ﹤0.01% 411
2019
Q3
– Sell
-12
Closed -$1K – 298
2019
Q2
$1K Buy
+12
New +$593 ﹤0.01% 464
2019
Q1
– Sell
-12
Closed -$1K – 265
2018
Q4
$1K Sell
12
-3
-20% -$154 ﹤0.01% 432
2018
Q3
$1K Hold
15
– – ﹤0.01% 435
2018
Q2
$1K Sell
15
-3
-17% -$149 ﹤0.01% 402
2018
Q1
$1K Sell
18
-6
-25% -$308 ﹤0.01% 382
2017
Q4
$2K Hold
24
– – ﹤0.01% 312
2017
Q3
$2K Sell
24
-6,537
-100% -$336K ﹤0.01% 316
2017
Q2
$340K Buy
6,561
+453
+7% +$22.9K 0.05% 197
2017
Q1
$308K Sell
6,108
-45
-0.7% -$2.23K 0.04% 203
2016
Q4
$290K Buy
+6,153
New +$292K 0.03% 201
2015
Q3
– Sell
-3
Closed -$1K – 874
2015
Q2
$1K Hold
3
– – ﹤0.01% 818
2015
Q1
$1K Hold
3
– – ﹤0.01% 817
2014
Q4
$1K Hold
3
– – ﹤0.01% 660
2014
Q3
$1K Hold
3
– – ﹤0.01% 621
2014
Q2
$1K Hold
3
– – ﹤0.01% 628
2014
Q1
$1K Buy
+3
New +$126 ﹤0.01% 592

Other funds holding IHE

Transamerica Financial Advisors's IHE Position: Q1 2024 in Review

Transamerica Financial Advisors sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2024, closing a stake of 3 shares — an estimated $1K sold.

Transamerica Financial Advisors first reported a position in IHE in Q1 2014 and held it in 23 quarters. The position peaked at $340K in Q2 2017. 143 funds tracked by Wall St. Rank hold IHE as of Q1 2024.

  • Transamerica Financial Advisors reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2024 after selling out during the quarter.
  • Transamerica Financial Advisors sold 3 iShares US Pharmaceuticals ETF shares in Q1 2024, an estimated $1K.
  • Transamerica Financial Advisors first reported a position in iShares US Pharmaceuticals ETF in Q1 2014 and held it in 23 quarters.
  • Transamerica Financial Advisors's iShares US Pharmaceuticals ETF position peaked at $340K in Q2 2017.
  • 143 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2024.

Based on Transamerica Financial Advisors's 13F filing for Q1 2024, filed 15 May 2024.